Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Balan

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Leukemia|April 26, 2014
Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease--friends or foes?A Balan, G Lucchini, S Schmidt, et al.
International Journal of Cancer|May 16, 1995
Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infectionsP Balaram, K R Nalinakumari, E Abraham, et al.
International Journal of Antimicrobial Agents|April 15, 2004
An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effectsDilip Nathwani, Jim Z Li, Dan A Balan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2022
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockadeX M Shao, J Huang, N Niknafs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2023
Corrigendum to "HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade": [Annals of Oncology volume 33 (2022) 728-738]X M Shao, J Huang, N Niknafs, et al.
Epilepsy & Behavior : E&B|March 1, 2003
Now you see it, now you don't: statistical and methodological considerations in fMRID W. Loring, K J. Meador, J D. Allison, et al.
Journal of the International Society of Sports Nutrition|September 24, 2024
A review of nutritional recommendations for scuba diversRhiannon J Brenner, Kiran A Balan, Marie P L Andersen, et al.
Clinical Therapeutics|July 16, 2003
Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trialHoracio López, Jim Z Li, Dan A Balan, et al.
Journal of Bacteriology|January 29, 2008
Genetic diversity of heat-labile toxin expressed by enterotoxigenic Escherichia coli strains isolated from humansM A Lasaro, J F Rodrigues, C Mathias-Santos, et al.
Physical Review Letters|August 20, 2013
Direct observation of thermal relaxation in artificial spin iceA Farhan, P M Derlet, A Kleibert, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Leukemia|April 26, 2014
Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease--friends or foes?A Balan, G Lucchini, S Schmidt, et al.
International Journal of Cancer|May 16, 1995
Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infectionsP Balaram, K R Nalinakumari, E Abraham, et al.
International Journal of Antimicrobial Agents|April 15, 2004
An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effectsDilip Nathwani, Jim Z Li, Dan A Balan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2022
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockadeX M Shao, J Huang, N Niknafs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2023
Corrigendum to "HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade": [Annals of Oncology volume 33 (2022) 728-738]X M Shao, J Huang, N Niknafs, et al.
Epilepsy & Behavior : E&B|March 1, 2003
Now you see it, now you don't: statistical and methodological considerations in fMRID W. Loring, K J. Meador, J D. Allison, et al.
Journal of the International Society of Sports Nutrition|September 24, 2024
A review of nutritional recommendations for scuba diversRhiannon J Brenner, Kiran A Balan, Marie P L Andersen, et al.
Clinical Therapeutics|July 16, 2003
Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trialHoracio López, Jim Z Li, Dan A Balan, et al.
Journal of Bacteriology|January 29, 2008
Genetic diversity of heat-labile toxin expressed by enterotoxigenic Escherichia coli strains isolated from humansM A Lasaro, J F Rodrigues, C Mathias-Santos, et al.
Physical Review Letters|August 20, 2013
Direct observation of thermal relaxation in artificial spin iceA Farhan, P M Derlet, A Kleibert, et al.
Pageof 6